发明名称 |
Molecular targets for ALS and related disorders |
摘要 |
Provided herein are compositions and methods for diagnosis, risk assessment, research, and therapy related to amyotrophic lateral sclerosis (ALS) and ALS-related disorders. In particular, the present invention relates to mutations in the UBQLN2 gene that cause dominantly inherited chromosome X-linked ALS and ALS/dementia. |
申请公布号 |
US9173897(B2) |
申请公布日期 |
2015.11.03 |
申请号 |
US201113313884 |
申请日期 |
2011.12.07 |
申请人 |
NORTHWESTERN UNIVERSITY |
发明人 |
Siddique Teepu;Chen Wenjie;Deng Han-Xiang;Yang Yi |
分类号 |
C12Q1/68;C12P19/34;A61K31/713 |
主分类号 |
C12Q1/68 |
代理机构 |
Foley & Lardner LLP |
代理人 |
Foley & Lardner LLP |
主权项 |
1. A method of detecting a mutation in a UBQLN2 nucleic acid in a human sample, comprising:
(a) contacting a UBQLN2 nucleic acid in a human sample with an oligonucleotide that specifically hybridizes to one or more missense mutations in a UBQLN2 nucleic acid, wherein the one or more missense mutations results in a substitution of a proline in the 12 P-X-X tandem repeats encoded by the UBQLN2 gene; and (b) detecting hybridization of the oligonucleotide with the UBQLN2 nucleic acid under specific hybridization conditions, wherein detection of hybridization is indicative of a mutation in the UBQLN2 nucleic acid. |
地址 |
Evanston IL US |